May 27 -- Valeant Pharmaceuticals International Inc. rose before U.S. markets opened after a report that the drugmaker rejected a takeover approach this spring from Takeda Pharmaceutical Co. and investment firm TPG. Bloomberg's Devin Banerjee reports on "Bloomberg ‹GO›."